BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:24 PM
 | 
Jul 11, 2007
 |  BC Extra  |  Clinical News

Allergy down on Pollinex Quattro hold

Allergy Therapeutics (LSE:AGY) fell 26p (22%) to 93p on Wednesday after FDA placed the company's clinical program for Pollinex Quattro vaccine on hold. The decision follows a report of a patient who developed neurological symptoms two months after receiving injections. The AE was classified...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >